Загрузка...
Preparation and radiolabeling of a lyophilized (kit) formulation of DOTA-rituximab with (90)Y and (111)In for domestic radioimmunotherapy and radioscintigraphy of Non-Hodgkin’s Lymphoma
BACKGROUND: On the basis of results of our previous investigations on (90)Y-DTPA-rituximab and in order to fulfil national demands to radioimmunoconjugates for radioscintigraphy and radioimmunotherapy of Non-Hodgkin’s Lymphoma (NHL), preparation and radiolabeling of a lyophilized formulation (kit) o...
Сохранить в:
| Опубликовано в: : | Daru |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4261883/ https://ncbi.nlm.nih.gov/pubmed/25074720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2008-2231-22-58 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|